Page 8 - Unity Biotechnology Inc News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Unity biotechnology inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Unity Biotechnology Inc Today - Breaking & Trending Today

25 States with the Highest Life Expectancy in the US

In this article, we will be taking a look at the 25 states with the highest life expectancy in the U.S. ....

United States , New Jersey , Rhode Island , North Dakota , Ada County , New York , Adams County , New Hampshire , Jeff Bezos , Yuri Milner , Athersys Inc , European Parliament , Agex Therapeutics Inc , Unity Biotechnology Inc , Altos Labs , Agex Therapeutics , Unity Biotechnology , York City , New England ,

Head-To-Head Contrast: Bolt Biotherapeutics (NASDAQ:BOLT) versus Unity Biotechnology (NASDAQ:UBX)

Bolt Biotherapeutics (NASDAQ:BOLT – Get Rating) and Unity Biotechnology (NASDAQ:UBX – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two companies based on the strength of their dividends, analyst recommendations, institutional ownership, risk, profitability, earnings and valuation. Earnings & Valuation This table compares Bolt Biotherapeutics and […] ....

Redwood City , United States , South San Francisco , Stanford University , Bristol Myers Squibb , Unity Biotechnology Inc , Forge Inc , Roche Ltd , Innovent Biologics Inc , Bolt Biotherapeutics Inc , Bolt Therapeutics Inc , Toray Industries , Get Rating , Unity Biotechnology , Innovent Biologics , Bolt Therapeutics , Bolt Biotherapeutics , Nasdaq Bolt , Stock Comparison , Stock Analysis ,

Unity Biotechnology (NASDAQ:UBX) Given New $6.00 Price Target at Citigroup

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price target upped by Citigroup from $5.00 to $6.00 in a report published on Friday, The Fly reports. Several other equities analysts also recently commented on the company. Wedbush decreased their target price on Unity Biotechnology from $35.00 to $5.00 and set an outperform rating on the […] ....

United Kingdom General , United Kingdom , Jan Van Deursen , Judith Campisi , Nathaniel Eames David , Blackrock Inc , Unity Biotechnology Inc , Arete Wealth Advisors , Unity Biotechnology Company Profile , Geode Capital Management , Unity Biotechnology , Get Rating , Wealth Advisors , Street Corp , Capital Management , Sigma Investments , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Boost Price Target , Citigroup Inc ,

Unity Biotechnology, Inc. (NASDAQ:UBX) Short Interest Update

Unity Biotechnology, Inc. (NASDAQ:UBX – Get Rating) saw a large drop in short interest in the month of May. As of May 15th, there was short interest totalling 952,200 shares, a drop of 17.2% from the April 30th total of 1,150,000 shares. Based on an average daily trading volume, of 417,800 shares, the days-to-cover ratio […] ....

Judith Campisi , Jan Van Deursen , Nathaniel Eames David , Virtu Financial , Capital Investment Advisors , Schonfeld Strategic Advisors , Unity Biotechnology Inc , Unity Biotechnology , Get Rating , Sigma Investments , Street Group , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx ,

Citigroup Boosts Unity Biotechnology (NASDAQ:UBX) Price Target to $6.00

Unity Biotechnology (NASDAQ:UBX – Get Rating) had its price objective boosted by Citigroup from $5.00 to $6.00 in a research report sent to investors on Friday morning, The Fly reports. Several other research firms also recently commented on UBX. Mizuho dropped their price objective on shares of Unity Biotechnology from $12.00 to $6.00 and set […] ....

Jan Van Deursen , Nathaniel Eames David , Judith Campisi , Unity Biotechnology Inc , Unity Biotechnology Company Profile , Virtu Financial , Capital Investment Advisors , Schonfeld Strategic Advisors , Unity Biotechnology , Get Rating , Sigma Investments , Street Group , Daohong Zhou , South San Francisco , Unity Biotechnology Daily , Nasdaq Ubx , Boost Price Target , Citigroup Inc ,